Cargando...
Discordance in investigator-reported and adjudicated sudden death in TIOSPIR
Accurate and consistent determination of cause of death is challenging in chronic obstructive pulmonary disease (COPD) patients. TIOSPIR (N=17 135) compared the safety and efficacy of tiotropium Respimat 5/2.5 µg with HandiHaler 18 µg in COPD patients. All-cause mortality was a primary end-point. A...
Guardado en:
| Publicado en: | ERJ Open Res |
|---|---|
| Autores principales: | , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
European Respiratory Society
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5358526/ https://ncbi.nlm.nih.gov/pubmed/28344980 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00073-2016 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|